BioCryst Pharmaceuticals, Inc. - BCRX

SEC FilingsOur BCRX Tweets

About Gravity Analytica

Recent News

  • 06.09.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
  • 06.09.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
  • 06.06.2025 - BioCryst Achieves Reimbursement for ORLADEYO Across all Major European Countries
  • 06.06.2025 - BioCryst Achieves Reimbursement for ORLADEYO Across all Major European Countries
  • 06.06.2025 - BioCryst Achieves Reimbursement for ORLADEYO Across all Major European Countries
  • 06.04.2025 - Jefferies Global Healthcare Conference
  • 06.04.2025 - Jefferies Global Healthcare Conference
  • 06.03.2025 - BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • 06.03.2025 - BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • 06.03.2025 - BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Recent Filings

  • 06.04.2025 - 8-K Current report
  • 06.03.2025 - 4 Statement of changes in beneficial ownership of securities
  • 06.03.2025 - 4 Statement of changes in beneficial ownership of securities